Trial Profile
Phase I/IIa trial of CS-TATI-1 in combination with GenePro in patients with HIV infections
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 01 Jun 2015
Price :
$35
*
At a glance
- Drugs CS TATI-1 (Primary) ; GenePro (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 01 Jun 2015 New trial record